Given the relevance of CD38 as a MM antigen and the attractive properties of the IgE antibody, we developed a fully human anti-CD38 IgE and evaluated its properties, including anti-cancer effects, in vitro and in vivo. This evidence concerns the gene IGHE and cancer.